GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ALSP Orchid Acquisition Corp I (NAS:ALOR) » Definitions » Asset Impairment Charge

ALSP Orchid Acquisition I (ALSP Orchid Acquisition I) Asset Impairment Charge : $0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ALSP Orchid Acquisition I Asset Impairment Charge?

ALSP Orchid Acquisition I's Asset Impairment Charge for the three months ended in Jun. 2023 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.


ALSP Orchid Acquisition I Asset Impairment Charge Historical Data

The historical data trend for ALSP Orchid Acquisition I's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ALSP Orchid Acquisition I Asset Impairment Charge Chart

ALSP Orchid Acquisition I Annual Data
Trend Dec21 Dec22
Asset Impairment Charge
- -

ALSP Orchid Acquisition I Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

ALSP Orchid Acquisition I Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


ALSP Orchid Acquisition I Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of ALSP Orchid Acquisition I's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


ALSP Orchid Acquisition I (ALSP Orchid Acquisition I) Business Description

Traded in Other Exchanges
N/A
Address
2815 Eastlake Avenue East, Suite 300, Seattle, WA, USA, 98102
ALSP Orchid Acquisition Corp I is a newly organized blank check company.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Thong Q. Le director, 10 percent owner, officer: Chief Executive Officer C/O ALSP ORCHID ACQUISITION CORP I, 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102
Carter Bruce L A director C/O ZYMOGENETICS, INC., 1201 EASTLAKE AVENUE, SEATTLE WA 98102
Mark W Hahn director 6340 QUADRANGLE DRIVE, SUITE 100, CHAPEL HILL NC 27517
Kendall Mohler officer: Chief Development Officer 2401 4TH AVE., SUITE 1050, SEATTLE WA 98121
Ian Howes director, 10 percent owner, officer: Chief Financial Officer C/O ALEXANDRIA AGRIFOODTECH, 26 NORTH EUCLID AVENUE, PASADENA CA 91101
Alsp Orchid Sponsor Llc 10 percent owner 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102
Sundar Kodiyalam director C/O ALSP ORCHID ACQUISITION CORP I, 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102
Stephanie Read director C/O ALSP ORCHID ACQUISITION CORP I, 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102
Kevin Chow officer: Chief Business Officer C/O ALSP ORCHID ACQUISITION CORP I, 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102
Andras Forgacs officer: Chief Operating Officer 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Eugene Yeo director C/O ALSP ORCHID ACQUISITION CORP I, 2815 EASTLAKE AVENUE EAST, SUITE 300, SEATTLE WA 98102